Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Olsalazine sodium
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Olsalazine 250mg capsules
0105010C0AAAAAA
|
Olsalazine sodium | Olsalazine sodium | Gastro-Intestinal System | 1,735 |
|
Olsalazine 500mg tablets
0105010C0AAADAD
|
Olsalazine sodium | Olsalazine sodium | Gastro-Intestinal System | 1,583 |
|
Dipentum 250mg capsules
0105010C0BBAAAA
|
Dipentum | Olsalazine sodium | Gastro-Intestinal System | No data available |
|
Dipentum 500mg tablets
0105010C0BBABAD
|
Dipentum | Olsalazine sodium | Gastro-Intestinal System | No data available |
|
Olsalazine 250mg/5ml oral liquid
0105010C0AAACAC
|
Olsalazine sodium | Olsalazine sodium | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.